# OnCo record pheon-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/pheon-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "pheon-therapeutics" ;
  schema:name "Pheon Therapeutics"@en ;
  schema:description "Pheon Therapeutics, of London, designs antibody-drug conjugates against an undisclosed target overexpressed across a wide range of solid tumours; its lead carries eight topoisomerase 1 inhibitor molecules per antibody and showed a wide therapeutic index preclinically. It raised a 120 million dollar Series B in 2024 and has entered early human trials."@en ;
  schema:url <https://onco.cc/companies/pheon-therapeutics/>, <https://pheontx.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pheontx.com/>, <https://pheontx.com/pheon-therapeutics-announces-120m-series-b-financing-to-fund-development-of-its-differentiated-adc-pipeline/> ;
  schema:addressCountry "GB" ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> .